We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
AUM
$149M
AUM Growth
-$355K
Cap. Flow
-$5.69M
Cap. Flow %
-3.82%
Top 10 Hldgs %
60.16%
Holding
219
New
19
Increased
55
Reduced
131
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Technology 8.1%
3 Consumer Staples 7.12%
4 Consumer Discretionary 6.29%
5 Industrials 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATO icon
76
Atmos Energy
ATO
$28.8B
$319K 0.21%
2,750
-126
-4% -$14.1K
NOW icon
77
ServiceNow
NOW
$115B
$316K 0.21%
2,235
-495
-18% -$62.4K
IBM icon
78
IBM
IBM
$211B
$315K 0.21%
1,929
-292
-13% -$44.1K
NI icon
79
NiSource
NI
$21.3B
$315K 0.21%
11,870
-298
-2% -$7.66K
MSFT icon
80
Microsoft
MSFT
$3.45T
$314K 0.21%
836
-142
-15% -$50.5K
EQIX icon
81
Equinix
EQIX
$101B
$314K 0.21%
390
-34
-8% -$26.1K
AWK icon
82
American Water Works
AWK
$26.7B
$313K 0.21%
2,375
-5
-0.2% -$630
DLR icon
83
Digital Realty Trust
DLR
$69.7B
$311K 0.21%
2,314
-208
-8% -$26.9K
T icon
84
AT&T
T
$159B
$310K 0.21%
18,448
-4,358
-19% -$68.8K
TPR icon
85
Tapestry
TPR
$30.8B
$309K 0.21%
8,381
-1,922
-19% -$59.2K
VZ icon
86
Verizon
VZ
$195B
$308K 0.21%
8,159
-1,657
-17% -$58.6K
RL icon
87
Ralph Lauren
RL
$22.6B
$307K 0.21%
2,131
-2,078
-49% -$257K
VRSN icon
88
VeriSign
VRSN
$26.2B
$302K 0.2%
1,467
-120
-8% -$25K
ENPH icon
89
Enphase Energy
ENPH
$4.96B
$300K 0.2%
2,274
+223
+11% +$23.7K
SNPS icon
90
Synopsys
SNPS
$74.4B
$300K 0.2%
582
-130
-18% -$66.5K
LULU icon
91
lululemon athletica
LULU
$13.5B
$293K 0.2%
+574
New +$248K
VFC icon
92
VF Corp
VFC
$5.63B
$291K 0.2%
15,485
-1,996
-11% -$34.2K
ORCL icon
93
Oracle
ORCL
$374B
$290K 0.19%
2,747
+145
+6% +$15.8K
MRNA icon
94
Moderna
MRNA
$21.8B
$290K 0.19%
2,912
+757
+35% +$63.7K
CTLT
95
DELISTED
CATALENT, INC.
CTLT
$283K 0.19%
6,297
+1,512
+32% +$61.2K
VRTX icon
96
Vertex Pharmaceuticals
VRTX
$121B
$271K 0.18%
666
-12
-2% -$4.43K
INCY icon
97
Incyte
INCY
$24.2B
$269K 0.18%
4,280
+659
+18% +$37.3K
MS icon
98
Morgan Stanley
MS
$331B
$265K 0.18%
2,844
-58
-2% -$4.64K
NKE icon
99
Nike
NKE
$61.9B
$263K 0.18%
2,422
-936
-28% -$101K
FCX icon
100
Freeport-McMoran
FCX
$90B
$261K 0.18%
6,137
-132
-2% -$4.88K

Similar funds

Vantage Consulting Group's Q4 2023 Portfolio in Review

As of Q4 2023, Vantage Consulting Group held 219 positions worth $149M, down 0.24% from $149M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Vantage Consulting Group withdrew a net $5.69M in Q4 2023, closing 11 positions and reducing 131 holdings. Its most notable exit was Royalty Pharma, an estimated $1.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Vantage Consulting Group opened a new position in Synchronoss Technologies worth $1.53M.

  • Vantage Consulting Group's largest Q4 2023 buy was Synchronoss Technologies: 245,947 shares worth $1.53M.
  • Vantage Consulting Group added most to TJX Companies in Q4 2023, an estimated $223K increase.
  • Vantage Consulting Group's biggest Q4 2023 reduction was Cibus, cutting an estimated $1.76M.
  • Vantage Consulting Group fully exited Royalty Pharma in Q4 2023, selling an estimated $1.56M.
  • Vantage Consulting Group's ten largest holdings make up 60% of its $149M portfolio in Q4 2023.
  • Vantage Consulting Group opened 19 new positions and closed 11 in Q4 2023.
  • Vantage Consulting Group's portfolio value fell 0.24% quarter-over-quarter to $149M.

Based on Vantage Consulting Group's 13F filing for Q4 2023, filed 14 Feb 2024.